Abstract
There is a growing consensus that continuous renal replacement therapy (1–4) is preferable to intermittent renal replacement in treating patients with acute renal failure (ARF). Continuous therapies are not associated with the rapid “unphysiologic” shifts in fluid and solutes which characterize intermittent hemodialysis (IHD). Conventional IHD utilizes diffusion based transport of solutes and fluid across cellulose acetate and cuprophane membranes. New membranes which use polysulphone, polyacrylonitrile or polyamide as the basic material are more permeable than IHD membranes and have a higher molecular weight cut off for enhanced clearance of middle molecules (5). Alternate renal replacement therapies have evolved with the availability of these membranes (6). Continuous Arteriovenous Hemofiltration/HemoDialysis (CAVH/CAVHD) is a new therapy rapidly gaining acceptance worldwide as the treatment of choice for ARF in critically ill, hemodynamically unstable, patients (7–10). This review describes the current status and discusses new developments of these techniques.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Kramer P, Schrader J, Bohnsack W, Greiden G, Groan HJ, Schaler F: Continuous arteriovenous hemofiltration: A new kidney replacement therapy. Proc Eur Dial Trans Assoc, 18: 743–749, 1981.
Lauer A, Sacaggi A, Ronco C, Belledonne M, Glabman S, Bosch JP: Continuous arteriovenous hemofiltration in the critically ill patient Ann Intern Med, 99: 455, 1983.
Kaplan AA, Longnecker RE, Folkert VW: Continuous arteriovenous hemofiltration — a report of six months experience. Ann Intern Med, 100: 358, 1984.
Weiss L, Danielson BG, Wikstrom B, Hedstrand U, Wahlberg J: Continuous arteriovenous hemofiltration in the treatmnet of 100 critically ill patients with acute renal failure: report on clinical outcome and nutritional aspects. Clin Nephrol, 31: 184–189, 1989.
Bosch JP: Continuous arteriovenous hemofiltration (CAVH): Operational characteristics and clinical use. AKF Nephrology, 3, 1986 (Letter).
Dickson DM, Hillman KM: Continuous renal replacement in the critically ill. Anesthes Intensiv Care, 18: 76–101, 1990.
Schneider NS, Geronemus RP: Continuous arteriovenous hemodialysis. Kidney Int, 5: 159–162, 1988.
Gibney RTN, Stollery DE, Lefebvre RE, et al: Continuous arteriovenous hemodialysis: An alternative therapy for acute renal failure associated with critical illness. Can Med Assoc J, 139: 861–866, 1988.
Bellomo R, Ernest D, Love J, Parkin G, Boyce N: Continuous arteriovenous hemodiafiltration: optimal therapy for acute renal failure in an intensive care setting? Aust N Zealand J Med, 20: 237–242, 1990.
Bartlett R, Bosch JP, Geronemus RP Paganini EP, Ronco C, Swartz R: Continuous arteriovenous hemo-filtration for acute renal failure: Workshop Summary. Trans Am Soc Art Int Org, 34: 67–77, 1988.
Scribner BH, Caner JEZ, Butri R, Quinton W: The technique of continuous hemodialysis. Trans Am Soc Artif Internal Organs, 6: 88–103, 1960.
New perspectives in hemodialysis, peritoneal dialysis, arteriovenous hemofiltration and plasmapheresis. Proc Int Symposium, Freiburg, Oct. 1988. Adv Exp Med Biol, 260: 1–213, 1989.
Paganini EP: Slow continuous hemofiltration and slow continuous ultrafiltration. Trans Am Soc Art Int Org, 34: 63–66, 1988.
Golper TA: Continuous AV hemofiltration in acute renal failure. Am J Kidney Dis, 6: 373–386, 1985.
Geronemus R, Schneider N: Continuous arteriovenous hemodialysis: A new modality for the treatment of acute renal failure. Trans Am Soc Art Int Org, 30: 610, 1984.
Menta RL, McDonald BR, Aguilar MM, Ward DM: Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients. Kidney Int, 38: 976–981, 1990.
Wendon J, Smithies M, Sheppard M, Bullen K, Tinker J, Binari D: Continuous high volume venous-venous hemofiltration in acute renal failure, hiten Care Med, 15: 358–363, 1989.
Sang YY, Uldall PR, Blake P, Francoeur R, Hall E, Besley M: Continuous veno-venous hemodialysis (CVVHD) in the management of complicated renal failure. J Cannt Spring 18–19, 1990.
Freudiger H, Levy M, Suter P, Favre H: Continuous veno-venous hemofiltration in acute renal insufficiency. Nephrologie, 11: 129–133, 1990.
Simpson K, Travers M, Allison M: Appropriate renal support in the management of acute renal and respiratory failure: Does early aggressive treatment improve outcome? In: “Current Concepts in Critical Care: Acute Renal Failure in the Intensive Therapy Unit” (Eds D Bihari and G Neild), Springer Verlag, New York, 1990, pp 311–318.
Hambroucx R, Bogaert AM, Leroy F, De Vos JY, Larno L: Go-slow dialysis instead of continuous arterio-venous hemofiltration. Intensiv Behandlung, 15:110, 1990.
Olbricht CJ, Haubitz H, Habel U, et al: Continuous arteriovenous hemofiltration: In vivo functional characteristics and its dependence on vascular access and filter design Nephron, 55: 49–57, 1990.
Jenkins R, Fink J, Chen B, Thacker D: Effect of access catheter dimensions on blood flow in CAVH: Intensiv Behandlung, 15: 111, 1990.
Ahmad Z: Introduction of percutaneous arteriovenous femoral shunt: A new access for continuous arteriovenous hemofiltration. Am J Kidney Dis, 16: 116–117, 1990.
Yohay DA, Schwab SJ, Quarter LD: Parallel plates are more effective than hollow fiber dialysis in continuous arteriovenous hemodialysis (CAVHD). J Am Soc Nephrol, 1: 382, 1990.
Vincent HH, Vos MC, deBakkev J, Ahckhauseyn E, van Duyl WA: Continuous A-V hemodiafiltration. Filter design and blood flow rate. Intensiv Behandlung, 15: 113–114, 1990.
Ronco C, Brendolan A, Milan M, Feriani M, Chiaramonte S, Bragantini L, La Greca G: Importance of hollow fiber geometry in CAVH. Intensiv Behandlung, 15: 112, 1990.
Siegler MH, Teehan BP: Solute transport in continuous hemodialysis: A new treatment for acute renal failure. Kidney Int, 32: 562–571, 1987.
Jenkins RD, Kuhn RJ, Funk JE: Permeability decay in CAVH hemofilters. Trans Am Soc Art Int Org, 34: 590–593, 1988.
Schultehis R, Brrings W, Glockner WM, Kierdort H, Sieberth HG: Gravimetric substitution help for controlled cyclic substitution during continuous hemofiltration. Intensiv Behandlung, 15: 112, 1990.
Sodemann K, Niedenthal A, Weber C, Schafer GE: Automated fluid balance in continuous hemodialysis (CHD) with blood safety module (BSM) 22. Intensiv Behandlung, 15: 113, 1990.
Heinrichs W, Mark S, Fauth U, Halmagyi M: An automatic system for fluid balance in continuous hemofiltration with very high precision. Intensiv Behandlung, 15: 110, 1990.
Mason JC: The role of spontaneous and pumped hemofiltration. In: “Acute renal failure in the intensive therapy unit” (Eds D Bihari and G Neild), Springer Verlag, London, 1990, pp 319–329.
Siegler MH, Teehan BP: Continuous arteriovenous hemodialysis. An improved technique for treating acute renal failure in critically ill patients. In: “Clinical Dialysis” (Eds AR Nissenson, RN Fine, DR Gentile) Second Edition, Appleton and Lange, Norwalk Connecticut, 1989, pp 720–734.
Golper TA, Leone M: Backtransport of dialysate solutes during in vitro continuous arteriovenous hemodialysis. Blood Purif, 7: 223–229, 1989.
Kaplan AA: The predilution mode for continuous arteriovenous nemo-filtration. In: “Acute Continuous Renal Replacement Therapy” (Ed E Paganini), Boston, Martinus Nirjhoff, 1986, p 143.
Davies SP, Kox WJ, Brown EA: Clearance studies in patients with acute renal failure treated by continuous arteriovenous haemodialysis. Intensiv Behandlung, 15: 106, 1990.
McDonald BR, Menta RL: Transmembrane flux of IL-IB and TNFα in patients undergoing continuous arteriovenous hemodialysis (CAVHD). J Am Soc Nephrol, 1: 368, 1990.
Golper TA, Jenkins R, Wright M, Klein JB: Tumor necrosis factor (TNF) and hemofiltration membranes. Intensiv Behandlung, 15: 119, 1990.
Bickley SK: Drug dosing during continuous arteriovenous hemofiltration. Clin Pharm, 7: 198–206, 1988.
Golper TA, Wedel SK, Kaplan AA, Saad AM, Donata ST, Paganini EP: Drug removal during continuous arteriovenous hemofiltration. Theory and clinical observations. Int J Art Org, 8: 307–312, 1985.
Geary JD, Davis G, Raju S: Cyclosporine pharmacokinetics in a lung transplant patient undergoing hemofiltration. Transplantation, 48: 710–712, 1989.
Lau A, Kronfol N, Powell S, Adams L: Effect of dialysate flow rate on drug removal by continuous arteriovenous hemodialysis. Am Soc Clin Pharamcol Ther, 45: 161, 1990.
Slugg PH, Haug M, Bosworth C, Paganini EP: Comparative vancomycin kinetics in ICU patients with acute renal failure: Intermittent hemodialysis vs continuous hemofiltration/hemodialysis. Intensiv Behandlung, 15: 108, 1990.
Reetze R, Bonier J, Keller D, Kohler C, Schollmeyer PJ: ElZination of vancomycin in patients on continuous arteriovenous hemodialysis. Intensiv Behandlung, 15: 108, 1990.
Bellomo R, Ernest D, Parker G, Bryce N: Clearance of vancomycin during continuous arteriovenous hemodiafdtration. Crit Care Med, 18: 181–183, 1990.
Kassum D, Light RB, Brown G, Krohn J, Fine A: Tobramycin clearance during continuous arteriovenous hemofiltration. J Crit Care, 2: 109–111, 1987.
Cigarran-Guldris S, Brier ME, Golper TA: Tobramycin clearance during simulated continuous hemodiafiltration. Intensiv Behandlung, 15: 106, 1990.
Weiss LG, Cars O, Danielson BG, Gardner A, Wickstrom B: Pharmacokinetics of intravenous cefuroxime during intermittent and continuous arterio-venous hemofiltration. Clin Nephrol, 30: 282–286, 1988.
Przecheva M, Bengel D, Rister T: Pharmacokinetics of imipenem/cilastin during continuous arteriovenous hemofiltration (CAVH). Intensiv Behand, 15: 107–108, 1990.
Zusman RM, Rubin RH, Cato AE, Cocchetto BS, Crow JW, Tolkoff-Rubin N: Hemodialysis using prostacyclin instead of heparin as the sole antithrombotic agent. N Engl J Med, 304: 934–939, 1981.
Schrader J, Scheler F: Coagulation disorders in acute renal failure and anticoagulation during CAVH with standard heparin and with low molecular weight heparin. In: “Continuous Arteriovenous Hemofiltration”, Int Conf on CAVH, Aachen Karger, Basel, 1985, pp 25–36.
Spinowitz BS: Anticoagulation in continuous arterioveous hemofiltration. In: “Acute Continuous Renal Replacement Therapy”, Proc Third Int Symp, Ft Lauderdale, Florida, 1987, pp 106–110.
Ronco C, Brendolan A, Borin D, Bragantini L, Fabris A, Feriane M, Chiaramonte S, La Greca G: Continuous arteriovenous hemofiltration in newborns. In: “Continous Arteriovenous Hemofiltration” (Eds HG Sieberth, H Mann) Karger, Basel, 1985, pp 76–79.
King DJ, Kelton JG: Heparin-associated thrombocytopenia. Ann Intern Med, 100: 535, 1984.
Schrader J, Stibbe W, Armstrong VW, Kandt M, Muche R, Köstering H, Seidel D, Scheler F: Comparison of low molecular weight heparin to standard heparin in Hemodialysis/hemofiltration. Kidney Int, 33: 890–896, 1988.
Moriniere P, Dieval J, Bayrou B, Roussel B, Renaud H, Fournier A, Delobel J: Low molecular-weight heparin fraxiparin in chronic hemodialysis. Blood Purif, 7: 301–308, 1989.
Schrader J, Stibbe W, Kandt M, Warneke G, Armstrong V, Muller HJ, Scheler F: Low molecular weight heparin versus standard heparin: a long-term study in hemodialysis and hemofiltration patients. Trans Am Soc Artif Int Org, 36: 28–32, 1990.
Hory B, Cachoux A, Toulemonde F: Continous arteriovenous hemofiltration with low-molecular-weight heparin. Nephron, 42: 125, 1985.
Wynckel A, Bernieh B, Toupance O, N’Guyen Ph. Wopng T, Lavaud s, Chanard J: Guidelines in using enoxaparin in slow continuous hemodialysis. Intensiv Behandlung, 15: 117, 1990.
Maher JF, Lapierre L, Schreiner GE, Geiger M, Westervelt FB Jr: Regional heparinisation for hemodialysis. N Engl J Med, 268: 451–456, 1963.
Kaplan AA, Petrillo R: Regional heparinization for continuous arterio-venous hemofiltration. Trans Am Soc Artif Int Org, 33: 312–315, 1987.
Schwab SJ, Onorato JJ, Sharar LR, Dennis PA: Hemodilaysis without anticoagulation. One year prospective trial in hospitalized patients at risk for bleeding. Am J Med, 83: 405–410, 1987.
Sanders PW, Taylor H, Curtis JJ: Hemodialysis without anticoagulation. Am J Kidney Dis, 5: 32–35, 1985.
Pinnick RV, Wiegmann TB, Diedrich DA: Regional citrate anticoagulation for hemodialysis in the patient at high risk for bleeding. N Engl J Med, 308: 258–263, 1983.
Von Brecht JH, Flanigan MJ, Freeman RM, Lim VS: Regional anticoagulation: Hemodialysis with hypertonic trisodium citrate. Am J Kidney Dis, 8: 196–201, 1986.
Menta RL, McDonald BR, Ward DM: Membrane transfer of citrate and calcium in regional citrate anticoagulation for continuous arteriovenous hemodialysis. J Am Soc Nephrol, 1: 368, 1990.
Menta RL, McDonald BR, Ward DM: Regional citrate anticoagulation for continuous arteriovenous hemodialysis. Intensiv Behandlung, 15: 116, 1990.
Gorman RR, Hamilton RD, Hopkins NK: Prostacyclin and thromboxane A2 biosynthesis and regulation of adenylate cyclase in human diploid cell lines. In: “Prostacyclin”, (Eds JR Vane, S Bergstrom), Raven Press, New York, 1979, pp 85–102.
Hory B, Saint-Hillier Y, Perol JC: Prostacyclin as the sole antithrombotic agent for acute renal failure hemodialysis. Nephron, 33: 71, 1983.
Maurin N: Antithrombotic management with a stable prostacyclin analogue during extracorporeal circulation. Intensive Behandlung, 15: 115, 1990.
Zobel G, Trop M, Muntean W, Ring E, Gleispach H: Anticoagulation for continuous arteriovenous hemofiltration in children. Blood Purif, 6: 90–95, 1988.
Stevens PE, Riley B, Davies SP, Gower PE, Brown EA, Kox CW: Continuous arteriovenous hemodialysis in critically ill patients. Lancet, II: 150–152, 1988.
Journois D, Chanu D, Castelain MH: Assessment of standardized ultrafiltrate production rate using prostacyclin (PGI2) in continuous venovenous hemofiltration (CHF). Intensiv Behandlung, 15: 115, 1990.
Ponikvar R, Kandus A, Buturovic J, Kveder R et al: Use of prostacyclin as the only anticoagulant during continuous veno venous hemofiltration. Intensive Behandlung, 15: 117, 1990.
Ota K, Kawaguchi H, Ito K: A new prostacyclin analogue: an anticoagulant applicable to hemodialysis. Trans Am Soc Art Int Org, 12: 31, 1983.
Taenaka N, Terada N, Takahashi H, Tachimori Y et al: Hemodialysis using gebexate mesilate in patients with a high bleeding risk. Crit Care Med, 14: 481–483, 1986.
Ohtake Y, Hirasawa H, Sugai T, Oda S et al: Nafamostat mesilate (NM) as anticoagulant in continuous hemofiltration (CHF) and continuous hemodiafiltration (CHDF). Intensiv Behandlung, 15: 116, 1990.
Costernino F, Paganini E, Lockrem J et al: Continuous arteriovenous hemofiltration (CAVH) in the adult respiratory distress syndrome (ARDS): a randomized controlled trial. Intensiv Behandlung, 15: 103, 1990.
Davenport A, Will EJ, Davison AM: Early changes in intracranial pressure during hemofiltration treatment in patients with grade 4 hepatic encephalopathy and acute oliguric renal failure. Nephrol Dial Transpl, 5: 192–198, 1990.
Marangoni R, Civardi F, Savino R, Masi F: Continuous arteriovenous hemofiltration (CAVH) improvement by adding diffusion and adsorption. Intensiv Behandlung, 15: 11, 1990.
Barzilay E, Kessler D, Lesmet C et al: Sequential plasma filter-dialysis with slow continuous hemofiltration: Additional treatment for sepsis induced ARF patients. J Crit Care, 3: 163–166, 1988.
Golper TA, Ronco C, Kaplan AA: Continuous arterivenous hemofiltration: Improvements, modifications and future directions. Semin Dial, 1: 50–54, 1988.
Raja R, Kramer M, Goldstein S et al: Comparison of continuous arteriovenous hemofiltration and continuous arteriovenous dialysis in critically ill patients. Trans Am Soc Art Int Org, 32: 435–436, 1986.
Alarabi AA, Danielson BG, Wikstrom B: Continuous dialysis in acute renal failure. Scand J Urol Nephrol, 24: 1–5, 1990.
Pattison ME, Lee SM, Ogden DA: Continuous arteriovenous hemodiafiltration: An aggressive approach to the management of acute renal failure. Am J Kidney Dis, 11: 43–47, 1988.
Paganini EP: Continuous renal prosthetic therapy in acute renal failure: an overview. Pediatr Clin North Am, 34: 165–185, 1987.
Di Carlo JV, Dudley TE, Sherbotie JR, Kaplan BS, Costarino AT: Continuous arteriovenous hemofiltration/dialysis improves pulmonary gas exchange in children with multiple organ system failure. Crit Care Med, 18: 822–826, 1990.
Bishof NA, Welch TR, Frederic Strife C, Ryckman FC: Continuous hemodiafiltration in children. Pediatrics, 85: 819–823, 1990.
Zobel G, Ring E, Zobel V: Continuous arteriovenous renal replacement systems for critically ill children. Pediatr Nephrol, 3: 140–143, 1989.
Heney D, Brocklebank JT, Wilson N: Continuous arteriovenous hemofiltration in the newlyborn with acute renal failure and congenital heart disease. Nephrol Dial Transpl, 4: 870–876, 1989.
Speri W, Geiger R, Maurer H, Guggenbichler JP: Continuous arteriovenous hemofiltration in hyperammonaemia of newborn babies. Lancet, 336: 1192–1193, 1990.
Zobel G, Haim M, Ritschl E, Muller W: Continuous arteriovenous hemofiltration as emergency procedure in severe hyperkalemia. Child Nephrol Urol, 9: 236, 1988-89.
Bartlett RH, Mault JR, Dechert RE, Palmer J, Swartz RD, Port FK: Continuous arteriovenous hemofiltration: improved survival in surgical acute renal failure. Surgery, 100: 400–408, 1986.
Chima C, Heyka R, Meyer L, Bosworth C, Hummel A, Paganini E: Nitrogen balance (NB) in postsurgical patients with acute renal failure on continuous arteriovenous hemofiltration (CAVH) and total parenteral nutriton (TPN). Intensiv Behandlung, 15:97, 1990.
McDonald BR, Menta RL, Ward DM: Decreased mortality in patients with acute renal failure (ARF) undergoing continuous arteriovenous hemodialysis (CAVHD) in the intensive care unit (ICU). Intensiv Behandlung, 15: 99, 1990.
Kuttnig M, Zobel G, Ring E, Trop M: Parenteral nutrition CAVH in critically ill anuric children. Intensiv Behandlung, 15: 121, 1990.
Voerman HI, Strack von Schjindel JM, Thijs LG: Continuous arteriovenous hemodiafiltration in critically ill patients. Crit Care Med, 18: 911–914, 1990.
Sigler MH, Snyder S, Teehan BP, Benz RL: Amino acid removal during continuous arteriovenous hemodialysis (CAVHD) in patients with acute renal failure (ARF) receiving total parenteral nutrition. Intensiv Behandlung, 15: 100, 1990.
Davenport A, Roberts NB: Amino acid losses during continuous high flux hemofiltration in the critically ill patient Crit Care Med, 17: 1010–1014, 1989.
Cameron JS: Acute renal failure — The continuing challenge. Q J Med, 228: 337–343, 1986.
Kjellstrand CM, Etten J, Davis T: Time of death, recovery of renal function, development of chronic renal failure, and need for chronic hemodialysis in patients with acute tubular necrosis. Trans Am Soc Artif Intern Organs, 27: 47–50, 1981.
Wilkins RG, Faragher EB: Acute renal failure in an intensive care unit: incidence, predicton and outcome. Anaesthesiology, 38: 638, 1983.
Knaus WA, Draper EA, Wagner DP, Zimmerman JE: APACHE II: a severity of disease classification system for acutely ill patients. Crit Care Med, 13: 818–829, 1985.
Dobkin JE, Cutler RE: Use of APACHE II classification to evaluate outcome of patients receiving hemodialysis in an intensive care unit. West J Med, 149: 547–550, 1988.
Kohen JA, Whitley KY, and Kjellstrand CM: Continuous arteriovenous hemofiltration: A comparison with hemodialysis in acute renal failure. Trans Am Soc Art Int Org, 31: 169, 1985.
Sieberth HG, Kierdorf H: Is continuous haemofiltration superior to intermittent dialysis and hemofiltration treatment? Adv Exp Med Biol, 260: 181–192, 1989.
Tarn PY, Huraib S, Mahan B, Le Blanc D, Lunski CA Holtzer C, Doyle CE, Vas SI, Uldall PR: Slow continuous dialysis in the management of complicated acute renal failure in an intensive care unit. Clin Nephrol, 30: 79–85, 1988.
Olbricht C, Mueller C, Schurek HJ: Treatment of acute renal failure in patients with multiple organ failure by continuous spontaneous hemofiltration. Trans Am Soc Artif Intern Organs, 28: 33, 1982.
Klehr HU, Kascell HJ, Kuchenbecker CH, Munch HG, Spannducker N: Clinical results of continuous arteriovenous hemofiltration. In: “Continuous Arteriovenous Hemofiltration (CAVH)” (Eds HG Sieberth, H Mann) Basel, Switzerland, Karger, 1985, pp 159–165.
Domoto DT: Two years experience with continuous arteriovenous hemofiltration in acute renal failure. Trans Am Soc Art Int Org, 31: 581–585, 1985.
Frisch S, Kindler J, Schmitter H, Glockner W, Seiberth H: Performance of CAVH in ARF therapy. In: “CAVH” (Eds G La Creca et al) Milan, Wichtig Editore, 1986, pp 283–288.
Mault JR, Dechert RE, Lees D, Swartz RD, Port FK, Bartlett RM: Continuous arteriovenous filtration: An effective treatment for surgical acute renal failure. Surgery 101: 478–484, 1987.
Lieberman KV: Continuous arteriovenous hemofiltration in children. Pediatr Nephrol, 1: 330–338, 1987.
Alarabi A, Brendolan A, Danielson BG et al: Outcome of continuous arteriovenous hemofiltration (CAVH) in acute renal failure (ARF): double-centre comparative study. Intensiv Behandlung, 15: 96, 1990.
Hirasawa H, Sugai T, Ohtake Y et al: Continuous hemofiltration (CHF) and hemodiafiltration (CHDF) in the management of multiple organ failure (MOF). Intensiv Behandlung, 15: 98, 1990.
Schreier P, Keusch G, Binswanger U: Outcome of acute renal failure in critically ill patients treated by continuous hemofiltration. Intensiv Behandlung, 15: 100, 1990.
Sluiter HE, Froberg L, van Dijl J, Go G: Mortality in high-risk intensive care patients with acute renal failure treated with CAVH. Intensiv Behandlung, 15: 101, 1990.
Zobel G, Ring E, Kuttnig M, Grubbauer HM: CAVH vs CVVH in critically ill pediatric patients. Intensiv Behandlung, 15: 121, 1990.
Canaud B, Cristol JP, Berthelemy C, Beraud JJ, Mion C: Acute renal failure (ARF) associated with multiple organ failure (MOF): pump assisted continuous veno-venous hemofiltration (CVVH) the ultimate treatment modality. Intensiv Behandlung, 15: 96, 1990.
Korner MM, Banayosy EL, Posival H: Ventricular assist device combined with continuous high volume venous-venous hemofiltration (CWH). Intensiv Behand, 3: 104, 1990.
Barzilay E, Wksler N, Kessler D et al: The use of continuous AV hemodialysis in the management of patients with oliguria associated with multiple organ failure. J Int Care Med, 14: 444–445, 1988.
Geronemus RP, Schneider NS, Epstein M: Survival in patients treated with continuous arteiovenous hemodialysis (CAVHD) for acute renal failure (ARF) and chronic renal failure (CRF). Intensiv Behandlung, 15: 97, 1990.
Keller E, Reetze P, Bonier J, Lucking FP, Schollmeyer P: Continuous arteriovenous hemodialysis (CAVHD): experience in 18 intensive care patients. Intensiv Behandlung, 15: 98, 1990.
Schafer GE, Sodemann K, Doring N, Schroder HM: Continuous arterio-venous (CAVHD) and veno-venous hemodialysis (CWHD) in critically ill patients. Intensive Behandlung 15: 100, 1990.
Bastien O, Saroul C, Estanove S: Continuous hemodialysis in acute renal failure following cardiac surgery. Intensiv Behandlung, 15: 101, 1990.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer-Verlag London Limited
About this chapter
Cite this chapter
Mehta, R.L. (1991). New Developments in Continuous Arteriovenous Hemofiltration/Dialysis. In: Andreucci, V.E., Fine, L.G. (eds) International Yearbook of Nephrology 1992. Springer, London. https://doi.org/10.1007/978-1-4471-1892-3_13
Download citation
DOI: https://doi.org/10.1007/978-1-4471-1892-3_13
Publisher Name: Springer, London
Print ISBN: 978-1-4471-1894-7
Online ISBN: 978-1-4471-1892-3
eBook Packages: Springer Book Archive